In very high-risk patients ( n = 73), a trend toward benefit was observed, though it did not reach statistical significance (HR = 0.56, 95% CI: 0.31–1.00.31.00, p = 0.06).
← all excerpts
Effects of dutasteride with Bacillus Calmette-Guérin therapy on recurrence, progression, metastasis, and survival in non-muscle invasive bladder cancer: a retrospective single-center study.
1
0.0600
0.0600